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Fluoroquinolones are a known antibacterial class commonly used around the world. These compounds 
present relative stability and they may show some adverse effects according their distinct chemical 
structures. The chemical hydrolysis of five fluoroquinolones was studied using alkaline and photolytic 
degradation aiming to observe the differences in molecular reactivity. DFT/B3LYP-6.31G* was used 
to assist with understanding the chemical structure degradation. Gemifloxacin underwent degradation 
in alkaline medium. Gemifloxacin and danofloxacin showed more degradation perceptual indices in 
comparison with ciprofloxacin, enrofloxacin and norfloxacin in photolytic conditions. Some structural 
features were observed which may influence degradation, such as the presence of five member rings 
attached to the quinolone ring and the electrostatic positive charges, showed in maps of potential 
electrostatic charges. These measurements may be used in the design of effective and more stable 
fluoroquinolones as well as the investigation of degradation products from stress stability assays.
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INTRODUCTION
Quinolones are a group of synthetic broad spectrum 
antibacterial drugs commonly used throughout the world. 
Nalidixic acid was the first compound introduced for 
therapeutics in 1962 for the treatment of urinary tract 
infections (Andersson, MacGowan, 2003; Petri, 2005). 
Different chemical changes to the basic structure of 
quinolones have been made over the years, aiming to 
improve the spectrum and antimicrobial activity and 
to minimize bacterial resistance. Currently, there are 
four generations of quinolones available for clinical use 
(Andersson, MacGowan, 2003; Petri, 2005), the main 
quinolones have a fluoro moiety attached to position 6 
of the fused ring. The basic chemical structure of 
fluoroquinolones is shown in Figure 1. 
The stability of drugs is a critical point of quality 
control and pharmacology for therapeutic agents, since 
a non-stable or reactive molecule may influence its 
structure, efficacy and safety. Stability tests, known as 
forced degradation studies, are important tools used to 
detect, quantify and identify the generation of degradation 
products (Alsante et al.; 2007; Singh et al., 2013). Forced 
degradation tests are applied by the pharmaceutical 
industry, usually under extreme conditions (ICH, 2003; 
FIGURE 1 - Basic chemical structure of fluoroquinolones.
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Klick, 2005; ICH, 2006a; ICH, 2006b; Silva et al., 
2009; Brasil, 2013), such as submitting the drug to acid, 
alkaline and oxidative media, high temperatures, and also 
to photolytic conditions. Among the cited conditions, 
alkaline and photolytic environments show a high capacity 
to promote degradation in the fluoroquinolone class. In 
fact, this compound class is unstable under photolytic 
conditions, i.e. fast degradation of these drugs occurs upon 
exposure to UV radiation (Burhenne, Ludwig, Spiteller, 
1999; Sunderland et al., 2001; Torniainen, Askolin, 
Mattinen, 2007; Paim et al., 2010). This instability 
promotes the formation of degradation products and may 
cause photosensitivity dermatitis (allergic or non-allergic), 
cytotoxicity and genotoxicity (Shimoda, 1998; Tokura, 
1998; Stahlmann, 1999; Paim et al., 2013).
Fluoroquinolones, however, present differences 
in their structure degradation when exposed to UV light 
and alkaline pH (Torniainen, Askolin, Mattinen, 2007; 
Paim et al., 2010; Babic´, Periša, Škoric, 2013; Ahmad 
et al., 2013). Different pathways of degradation have 
been shown, as well as photochemistry reactions among 
the various compounds. This indicates the necessity of 
understanding the differences in reactivity among the 
fluoroquinolones.
Molecular modelling is a set of computational tools 
based on theoretical methods of calculation largely used 
in drug design to understand the molecular structure and 
physicochemical properties of compounds with biological 
or chemical interest (Carvalho et al., 2003). Thus, in silico 
calculations are able to provide information about the 
behavior of molecules under specific circumstances, which 
may elucidate, theoretically, the stability of the quinolone 
class under certain conditions. These methodologies may 
be used to explain the degradation of quinolone chemical 
structures and also to identify some aspects which may 
influence their molecular reactivity (Kieffer et al., 2010; 
Kleinman et al., 2015). 
The aim of this study was to explain changes to 
the chemical structure of five quinolones, including 
norfloxacin, ciprofloxacin, enrofloxacin, danofloxacin and 
gemifloxacin, under the influence of alkaline medium and 
UV light, using computational tools. These data may be 
used to understand the stability of these chemical structures 
and also to help the study of new fluoroquinolones drugs 
design. 
MATERIAL AND METHODS
All chemicals used were of analytical grade and 
all solvents were of chromatographic grade. Methanol, 
acetonitrile and triethylamine (TEA) were obtained 
from Merck® (Darmstadt, Germany), while phosphoric 
acid was acquired from Vetec® (Duque de Caxias-RS, 
Brazil). Purified water was prepared using a Milli-Q Plus® 
system (Bedford, USA). Standard reference danofloxacin, 
enrofloxacin, norfloxacin and ciprofloxacin hydrochloride 
with purity of ≥ 98% were obtained from Sigma-Aldrich 
(St. Louis, USA). Standard reference gemifloxacin 
mesylate (99%) was acquired from Toronto Research 
Chemicals, Inc. (Toronto, Canada). 
Apparatus
A Shimadzu liquid chromatograph (Kyoto, Japan) 
equipped with an LC-20AT pump, an SIL-20A auto 
sampler, a CTO-20A column oven, a SPD-20AT 
photodiode-array detector and LC Solution V. 1.24 SP1 
manager system software was used. A Millipore® nylon 
filter (13 mm x 0.45 μm) was used to filter the samples 
before injection. Separation was performed by an Agilent 
Zorbax® C-18 reverse phase column (250 mm x 4.6 mm 
x 5 µm ID). Photodegradation studies were carried out in 
a photostability UV chamber (0.98 cm x 0.24 m x 0.25 m 
height) coated with mirrors and equipped with UV-A and 
UV-C lamps (Light Express®, 352 nm, 30W and Ecolume 
ZW®, 254 nm, 30W, respectively).
Chromatographic conditions
Each standard reference was performed according 
to the United States Pharmacopeia (USP, 2009), using the 
reported or validated method with minor modifications, 
in which each mobile phase was filtered through a 
0.45 μm nylon filter and degassed in an ultrasonic bath 
before use and stored in a dark closed flask at 4 ºC. The 
chromatographic conditions are provided in Table I.
Preparation of quinolone standards, alkaline and 
photolytic degradation study Alkaline degradation
Ciprofloxacin hydrochloride, danofloxacin, 
enrofloxacin, gemifloxacin and norfloxacin were 
accurately weighed (10 mg) and dissolved in a 100 
mL volumetric flask with 0.1 mol L-1 NaOH, obtaining 
a concentration of 100 µg mL-1 for each drug. The 
solutions were filtered through a 0.45 µm membrane filter. 
Subsequently, 1.0 mL of each solution was placed in a 10 
mL volumetric flask and stored at room temperature (21-
23 °C) in the dark for 1 or 3 h. Then, these solutions were 
removed, neutralized with 0.1 mol L-1 HCl and diluted with 
methanol to achieve a concentration of 15 µg mL-1. To zero 
time results was measured immediately after dilution and 
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they were considered 100%. Results determined from all 
times were compared to each other.
Photolytic degradation
Ciprofloxacin hydrochloride, danofloxacin, 
enrofloxacin, gemifloxacin mesylate and norfloxacin were 
accurately weighed (10 mg) and dissolved in a 100 mL 
volumetric flask with methanol, obtaining a concentration 
of 100 µg mL-1 for each drug. The solutions were filtered 
through a 0.45 µm membrane filter. Subsequently, 1.5 
mL of each solution was placed in a semi-micro UV-
cuvette, sealed with parafilm (American Co. Brand, 
USA) and immediately placed in the UV chamber for 
the photodegradation study for 5, 15 or 30 minutes (three 
replicates per period). After the photolytic degradation 
study, the cuvette solutions were placed to a 10 mL 
volumetric flask and diluted with methanol (to 15 µg 
mL-1). Then, a 1 mL aliquot of the solution was placed in 
a vial and 20 µL were injected into the chromatographic 
system. To zero time results was measured immediately 
after dilution and they were considered 100%. Results 
determined from all times were compared to each other. 
Statistical analysis
Data analysis was performed using GraphPad Prism 
5 (GraphPad Software, La Jolla, USA). Two-way ANOVA 
was used to investigate the results of the photolytic 
degradation study and descriptive statistics are expressed 
as mean + standard deviation (SD). For better visualization 
of the results, the absolute area from the solution measured 
immediately after dilution was considered as 100% and 
it was compared to the results from 5, 15 and 30 minutes 
of treatment. The Bonferroni post-hoc test was used for 
multiple comparisons and a p value < 0.05 was considered 
statistically significant.
Computational tools
The computational analyses were performed using 
Spartan 08® version for Windows (Wavefunction, Inc., 
USA) and all initial structures were built using atoms 
and structural fragments from its molecular editor. 
Geometry optimization was performed in the gaseous 
phase using Density Functional Theory (DFT), and the 
Becke three-parameter hybrid (B3) associated with Lee-
Yang-Parr (LYP) correlation functionals, i.e. the B3LYP 
method, with the 6.31G* basis set. Maps of HOMO and 
LUMO energies and electrostatic potential (MEPs) were 
also calculated. The isosurface of MEPs was obtained 
at the van der Waals contact surface, which represents 
the potentials superimposed onto a surface of constant 
electron density (0.002 e/au3). The isoenergy contours 
TABLE I - Chromatography conditions for the analysis of the products of forced degradation tests
Standard  
Reference
Aqueous 
solution 
(A)
pH
Organic 
solution 
(B)
Proportion 
(A:B)
Flow 
(mL/min)
Oven  
(T ºC)
Wavelength 
(nm)
Ciprofloxacin
H3PO4 0.025 M 
adjusted with 
TEA1
3 Acetonitrile: H2O (80:20)
87:13 1.5 30 278
Danofloxacin
TEA 0.3% 
adjusted with 
formic acid2
3 Acetonitrile: H2O (80:20)
75:25 1.0 30 283
Enrofloxacin
KH2PO4 0.04 
M with TEA 
0.3%3
2.7 Acetonitrile: H2O (80:20)
76:24 1.0 30 278
Gemifloxacin
TEA 0.3% 
adjusted with 
H3PO44
3 Acetonitrile: H2O (80:20)
72:28 1.5 25 272
Norfloxacin
H2O:H3PO4 
(1000:1) 
adjusted with 
TEA1
2.5 Acetonitrile: H2O (80:20)
80:20 1.0 40 275
+TEA, triethylamine; H2O, ultra-pure water; 
1United States Pharmacopeia (USP 32); 2Liu et al., 2011; 3Method home validated; 
4Paim et al., 2010.
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were generated in the range of 35 to 60 kcal mol-1. The 
color intensity indicates more or less positive or negative 
electrostatic regions in the molecule. All color-coded 
surfaces obtained from these calculations provided a 
measure of the overall size of the molecular fragment 
and the location of positive, characterized by blue, and 
negative, indicated by green (less negative) and red (more 
intensely negative) electrostatic potentials. HOMO and 
LUMO isosurfaces were calculated at 0.0032 au2. The 
constants used in these isosurface calculations were the 
default parameters in Spartan software.
RESULTS AND DISCUSSION
In general, quinolones shows fast degradation under 
photolytic conditions, demonstrating high susceptibility 
to drug degradation when exposed to UV radiation, as 
described in the literature (Burhenne, Ludwig, Spiteller, 
1999; Sunderland et al., 2001; Torniainen, Askolin, 
Mattinen 2007; Paim et al., 2010). Alsante et al. (2007) 
suggested a degradation of 5-20% for establishing 
a stability method, since intermediate degradation 
products should not interfere in drug analysis. Liquid 
chromatography procedures showed adequate resolution 
for all quinolones and degradation products generated by 
photolytic and alkaline degradation. 
The alkaline stress conditions used in this work 
were set in accordance with Paim et al. (2013). In this 
procedure, only gemifloxacin showed degradation at 1 and 
3 hours in the presence of 0.1 mol L-1 NaOH among the 
five compounds evaluated. For norfloxacin, ciprofloxacin, 
danofloxacin and enrofloxacin, no significant degradation 
occurred in alkaline medium at 5 and 15 minutes (Table II). 
Similar results were found in the literature, despite the 
different conditions tested. Ciprofloxacin showed 2.9% 
of degradation in 0.5 mol L-1 NaOH at 50°C under reflux 
for 5 h (Vaghela, Rao, 2013) and no degradation was 
observed for danofloxacin and enrofloxacin when exposed 
to 0.1 mol L-1 NaOH at 80 °C for 24 h (Liu et al., 2011) 
and 5.0 mol L-1 NaOH at 70 °C for 1 h (Chakravarthy, 
Sailaja, Kumar, 2015), respectively. Nevertheless, 18.9% 
norfloxacin degradation was found when diluted in 
acetonitrile and degraded with 1.0 mol L-1 NaOH at 70 °C 
for 11 days. A strong alkaline solution and a long period 
of time was required for this fluoroquinolone to achieve 
these degradation values. 
Fluoroquinolones show instability in the photolytic 
test as demonstrated for some compounds such as 
ciprofloxacin, danofloxacin, clinafloxacin, enrofloxacin, 
gemifloxacin, levofloxacin, norfloxacin, ofloxacin, 
sitafloxacin and sparfloxacin (Engler et al., 1998; Shimoda, 
1998; Burhenne, Ludwig, Spiteller, 1999; Lovdahl, Priebe, 
2000; Sunderland et al., 2001; Torniainen, Askolin, 
Mattinen, 2007; Paim et al., 2010; Babic´, Periša, Škoric, 
2013;). The results show relative stability under photolytic 
conditions for 5 minutes for ciprofloxacin, norfloxacin 
and enrofloxacin, while danofloxacin and gemifloxacin 
were unstable (>5% degradation). Ciprofloxacin and 
enrofloxacin underwent photodegradation after 15 minutes 
and norfloxacin remained stable under the influence of 
UV light within the time interval evaluated. In this regard, 
norfloxacin was considered the most stable drug among 
the tested fluoroquinolones (Table III). 
Two-way ANOVA was performed to verify if there 
were significant differences among the fluoroquinolones 
TABLE II - Forced degradation study for fluoroquinolones using 
0.1 mol L-1 NaOH in room temperature (21-23 °C)
Fluoroquinolone 1 hour (%) ± RSD
3 hours (%) 
± RSD
Ciprofloxacin 100.24 + 2.29 98.17 + 0.22
Enrofloxacin 100.55 + 1.28 100.92 + 0.32
Danofloxacino 101.07 + 0.49 102.50 + 0.41
Gemifloxacin 26.91 + 3.62 -
Norfloxacin 101.10 + 0.54 101.63 + 2.08
TABLE III - Degradation forced studies for fluoroquinolones using UVC radiation (254 nm)
Fluoroquinolone 5 minutes (%) ± RSD
15 minutes 
(%) ± RSD
30 minutes 
(%) ± RSD
Ciprofloxacin 95.8 ± 1.34 95.0 ± 3.97 93.5 ± 3.80
Enrofloxacin 96.8 ± 1.03 92.9 ± 2.33 91.5 ± 1.91
Danofloxacin 93.4 ± 1.03 92.3 ± 0.28 91.1 ± 1.91
Gemifloxacin 82.4 ± 1.37 49.7 ± 0.78 25.4 ± 1.27
Norfloxacin 97.8 ± 1.33 98.2 ± 1.55 99.5 ± 2.44
Media ± standard deviation are expressed in percentage. RSD, relative standard deviation
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relative to degradation by the action of UVC 254 nm light. 
According to the results, there were significant differences 
between gemifloxacin and the other fluoroquinolones at 
all time points tested (p<0.001). 
Ciprofloxacin and enrofloxacin showed significant 
differences after 30 minutes of UV light exposure 
(p<0.01) when compared to norfloxacin. Enrofloxacin 
also demonstrate in 15 minutes (p<0.01 and p<0.001). 
Significant differences were showed by danofloxacin 
throughout the experiment when compared with 
norfloxacin (5 minutes, p<0.05; 15 minutes, p<0.01; 30 
minutes, p<0.001). The results are shown in Figure 2.
Fluoroquinolone behavior in the photolytic assay 
(0-30 min) demonstrated the absence of chromatographic 
coelution of impurities and/or degradation products from 
ciprofloxacin, enrofloxacin, danofloxacin, norfloxacin 
and gemifloxacin in the conditions tested. Peak purity 
tools showed the absence of impurities and/or degradation 
products from ciprofloxacin, enrofloxacin, danofloxacin, 
norfloxacin and gemifloxacin peaks in the photolytic assay. 
In fact, only gemifloxacin showed visible degradation 
products in the chromatogram under the tested conditions. 
These results are shown in Figure 3.
Computational procedures
The DFT method using the B3LYP functional and 
the 6.31G* basis set was used to optimize the geometry of 
the chemical structures of the five fluoroquinolones in the 
gaseous phase. Chemical structures in space filling, tube 
and maps of energies of density of electrostatic potential 
(MEP), of HOMO and LUMO were generated in this 
step. The properties of EHOMO, ELUMO and GAP (ELUMO-
EHOMO) were calculated and used to study the reactivity of 
fluoroquinolones. All structures, maps and physicochemical 
properties are shown in Figure 4 and Table IV. 
The main structural differences among the five 
fluoroquinolones are the moieties attached at positions 
FIGURE 2 – Results of degradation of fluoroquinolones after UVC radiation under photolytic conditions (A) and expanded 
graphic to 100-75% peak axis area (B). Media and standard deviation are expressed in percentage. * means statistical difference p 
<0.05 compared to norfloxacin; ** means statistical difference p<0.01 to norfloxacin; *** means statistical difference p<0.001 to 
norfloxacin; # means statistical difference p <0.001 between gemifloxacin compared to other fluoroquinolones.
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1 and 7 of the quinolone ring, and the nitrogen atom at 
position 8. Norfloxacin shows an ethyl moiety attached 
at position 1 in comparison to the other fluoroquinolones 
which present a cyclopropane ring attached at this 
position. The fluoroquinolones tube models showed a 
similar structure, in which the quinolone ring is not a 
coplanar structure with carboxylic acid and substituent 
groups are attached to positions 1 and 7. In the space filling 
models, it is possible to observe that the lateral chain is 
higher according to gemifloxacin>danofloxacin>enroflox
acin>ciprofloxacin≈ norfloxacin. 
MEPs, HOMO and LUMO maps were generated 
in order to understand the mechanism of degradation 
of fluoroquinolone chemical structures, since these 
properties are generally associated with the reactivity and 
stability of compounds. Fluoroquinolone MEPs showed 
the electronegative value range around the molecules, 
but with high sites of this property in the carboxylic acid 
and the quinolone ring as well as the nitrogen atom of 
the piperazine ring. Sites of positive electrostatic charge 
were located in the hydrogen atom of carboxylic acid 
and at the ethyl or cyclopropane ring. The HOMO and 
LUMO energy sites are shown in Figure 4. HOMO sites 
were almost evenly distributed around the structures; 
however, gemifloxacin and ciprofloxacin showed lower 
sites in the ring attached at position 7 in comparison with 
enrofloxacin, danofloxacin and norfloxacin. LUMO sites 
were located mainly at the quinolone ring. No differences 
were observed among the fluoroquinolones studied.
Evaluation of the influence of chemical structure 
on fluoroquinolone degradation
Gemifloxacin was the most unstable compound 
under both alkaline and photolytic conditions when this 
molecule was compared with other fluoroquinolones. 
The presence of a five member ring attached at position 7 
and a nitrogen atom instead carbon located at position 8 
of the quinolone ring may influence the reactivity of 
this molecule. In this sense, observing the MEPs, the 
nitrogen atom of the quinolone ring showed more negative 
electrostatic potential located at this position, which was 
different from the other fluoroquinolones.
In the alkaline forced stress test, ciprofloxacin, 
enrofloxacin, danofloxacin and norfloxacin showed a 
similar profile of degradation (Table II). Considering the 
maps and the calculated physicochemical properties, it 
was observed that gemifloxacin and ciprofloxacin showed 
lower EHOMO sites in the rings attached at position 7. 
This property, however, appears to have no influence 
on the alkaline degradation of these compounds since 
ciprofloxacin did not undergo alkaline degradation. 
Gemifloxacin showed a higher value of ELUMO, -1.33 
eV, in comparison with the other compounds, but this 
property, as well as the tube and space filling models and 
GAP energy, did not show characteristics which may 
help in understanding alkaline stability under the studied 
conditions.
In the photolytic degradation study, norfloxacin was 
the most stable compound compared to the other four 
fluoroquinolones (Figure 2). The presence of an ethyl 
moiety in relation to cyclopropane is the main difference 
and may suggest that the presence of a three membered 
ring promotes instability in the fluoroquinolone structure. 
This feature is in agreement with a study by Babic´, Periša 
and, Škoric (2013), which demonstrated cyclopropane ring 
cleavage in enrofloxacin when submitted to photolytic 
conditions.
Danofloxacin and gemifloxacin were found to be 
the most unstable compounds after five minutes of the 
photolytic assay. Paim et al. (2016) performed a photolytic 
degradation study of gemifloxacin in which a product from 
FIGURE 3 - Chromatograms of fluoroquinolones after treatment in photolytic conditions at time of 0 and 30 minutes. 
Chromatographic conditions describing in Table I. 
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FIGURE 4 - Chemical structure, space filing model, MEPs, maps of HOMO and LUMO energy 3D distribution of fluoroquinolones. 
I – Space filing model; II- MEPs; III – HOMO energy; IV – LUMO energy. MEPs 3D, tube and space filling models obtained from 
DFT/3BLYP-6.31G* calculations using Spartan’08 for Windons with isosurface 0.002 eV. Color range: -60.000 (red) to 35.000 
(blue) kcal mol-1.
TABLE IV - Energy of HOMO, LUMO and GAP eigenvalues obtained from DFT/3BLYP-6.31G* calculations using Spartan’08 
for Windows
Quinolone EHOMO (-) eV ELUMO (-) eV GAP (-) eV
Ciprofloxacin 5.70 1.20 4.50
Enrofloxacin 5.68 1.19 4.49
Danofloxacin 5.44 1.11 4.33
Gemifloxacin 5.67 1.33 4.34
Norfloxacin 5.46 1.22 4.24
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the original fluoroquinolone with a structure missing the 
ring attached to position 7 was isolated and identified. 
Danofloxacin has five and six member fused rings similar 
to the five member ring of gemifloxacin, which may 
explain the enhanced degradation observed in comparison 
with norfloxacin, ciprofloxacin and enrofloxacin. These 
three compounds have a piperazine ring attached to 
position 7 of the quinolone nucleus and which may make 
these molecules more stable under photolytic conditions. 
Babic´, Periša, Škoric (2013) suggested the oxidative 
photodegradation of enrofloxacin and ciprofloxacin may 
occur at the piperazine ring attached at position 7 by 
opening the ring. In another study, Hubicka et al. (2014) 
identified sixteen degradation products of danofloxacin 
by LC-MS/MS when it was submitted to photolytic tests. 
All of them showed alterations mainly at the fused rings 
of the lateral chain. Additionally, Sturini et al. (2012) 
showed fluoroquinolone degradation under photocatalytic 
conditions using TiO2; they indicated five member rings 
may be more unstable than six member rings. These data 
confirm the influence of the substituent moieties attached 
at position 7 on the stability of fluoroquinolone structures.
Gemifloxacin presents a nitrogen atom on the 
quinolone ring with more negative electrostatic potential 
located at this position; this may indicate a more 
susceptible site for interactions with photolytic energy. 
Similar to alkaline conditions, the physicochemical 
properties such as EHOMO, ELUMO and GAP, the maps of 
the molecular orbitals (HOMO and LUMO), as well as 
the tube and space filling models do not show differences 
that explain the distinct photolytic degradation behavior 
under the studied conditions. It has been suggested to 
apply the concepts of Fukui indices or to determine bond 
dissociation enthalpies in order to predict the susceptibility 
of fluoroquinolone degradation in an alkaline or photolytic 
environment. These procedures may be important to 
understand the degradation process, but they are not within 
the scope of this study.
The differences in stability of the five studied 
fluoroquinolones should be considered because they 
provide an appropriate comparison among the drugs. 
Structural features of these compounds may be used in 
the design of effective and more stable fluoroquinolones. 
These results are also important since they may increase 
efficacy and establish the shelf life of the drug product. 
CONCLUSION
These studies suggest greater instability of 
gemifloxacin in comparison with the other fluoroquinolones 
under all conditions evaluated. A photolytic environment 
causes degradation of this class of compound and they 
must be protected from UV light. Chemical structure of 
these compounds or, specifically, the moiety attached to the 
quinolone ring should be strongly considered according 
with the influence on stability. MEPs are an interesting 
tool for the description of fluoroquinolone reactivity and 
can be used to investigate degradation products in stress 
stability studies.
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